Table 4.

Serum Cathelicidin in Children with IBD Depending on the Treatment Status Compared to the Control Group

Parameters	Groups	Mean	SD	Median	Range	Statistical Analysis
Cathelicidin[ng/mL]	Patients with IBD treatment naïve(n=25)	1076.98	181.49	1095.50	742.31–1473.33	H=16.31; p=0.0003*^
	Patients with IBD on any treatment(n=43)	1062.13	211.93	1077.84	621.38–2028.39
	Control group(n=20)	890.56	129.37	918.47	616.46–1091.76

Notes: *p<0.05 when comparing children with IBD treatment naïve and controls; ^p<0.05 when comparing children with IBD on medications and controls.